Karachi, AGP Limitedinformed Pakistan Stock Exchange that they are holding an Analyst Briefing to discuss financial result for the half year ended June 30, 2018. In this regard they are inviting Security Analysts / Research Analysts, Members of the Pakistan Stock Exchange, Bankers and general investors to attend the meeting.
AGP Limited (AGP) began its commercial operations in 1989 as an independent pharmaceutical manufacturing company in Karachi, Pakistan. It has steadily grown through manufacturing and marketing products under licensing arrangements with many companies of international repute and also through manufacturing and marketing its own brands. Today, it is one of the largest pharmaceutical companies in Pakistan, providing a broad range of pharmaceutical products. The determination to upgrade the pharmaceutical resources of Pakistan and improvement of the quality of life of a common man was the key motivating factors in the inception of AGP.
The operations of AGP include manufacturing, marketing and sales of pharmaceuticals and healthcare products in the domestic and export market. The delivery of AGP’s products, across the country, is managed by one of the largest and state of art pharmaceutical distribution set ups in Pakistan.